Bilobectomy for non-small cell lung cancer: A search for clinical factors that may affect perioperative morbidity and long-term survival

Bilobectomy can be performed with acceptable morbidity and mortality. Survival relates to disease stage. Optimal survival benefit occurs when the indication for bilobectomy is squamous cell carcinoma extending across the fissure.